Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 46Recruiting 19Active not recruiting 19Terminated 15Unknown 13Withdrawn 7Not yet recruiting 3

Sponsor Class

OTHER 3INDUSTRY 1FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Abiraterone Acetate 1

Interventions

Drug Therapy 107Cisplatin 98Radiotherapy 89Carboplatin 86Bevacizumab 79Oxaliplatin 74Capecitabine 69tislelizumab 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 58pembrolizumab 56Specimen Handling 54sintilimab 53Surgical Procedures, Operative 52anlotinib 51Magnetic Resonance Spectroscopy 50Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35Leucovorin 34lenvatinib 33venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Abiraterone Acetate × Clear all
NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting
400 enrolled
Genitourinary

Abiraterone Acetate

NCT06500247 2024-07-15

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting
43 enrolled
Genitourinary

Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Medical University of Vienna

Not yet recruiting
500 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡